Spots Global Cancer Trial Database for A Study of BPI-460372 in Advanced Solid Tumor Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of BPI-460372 in Advanced Solid Tumor Patients
Official Title: A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BPI-460372 in Advanced Solid Tumor Patients
Study ID: NCT05789602
Conditions
Interventions
Study Description
Brief Summary: This study is an open-label, single arm, dose escalation and dose expansion phase 1 study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of BPI-460372 in solid tumor patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking Union Medical College Hospital, Beijing, Beijing, China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Affiliated Hospital of Hebei University, Baoding, Hebei, China
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
Tongji Hospital Tongji Medical College of HUST, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
China-Japan Union Hospital of Jilin University, Changchun, Jilin, China
Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
Shandong Cancer Hospital, Jinan, Shandong, China
Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Zhengzhou, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
